Lupin Launches Dasatinib Tablets in the US Market
Lupin Limited has launched Dasatinib Tablets in the United States, available in 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg dosages. The…
Hindustan Aeronautics Clarification on Russia Aircraft Manufacturing Collaboration
Hindustan Aeronautics Limited (HAL) clarifies a news item regarding collaboration with Russia on aircraft manufacturing. HAL confirms it…
Ajanta Pharma Analyst/Institutional Investor Meeting Schedule
Ajanta Pharma has announced the schedule for upcoming Analyst/Institutional Investor Meetings. The schedule includes three meetings: Axis…
Oil India Limited Clarification on Seismic Studies for OALP-X Bidding
Oil India Limited clarified news regarding seismic studies for OALP-X bidding. The Chairman and Managing Director responded to a query from…
Tata Teleservices Clarification on Volume Movement
Tata Teleservices (Maharashtra) Limited has issued a statement clarifying that they are compliant with information disclosure norms. They…
Vardhman Textiles Clarification on Recent Increase in Trading Volume
Vardhman Textiles has addressed inquiries regarding a significant increase in the volume of the company’s stock trading across…
Lupin Partners with TB Alliance to Advance Telacebec
Lupin has announced a strategic collaboration with TB Alliance to advance the clinical development and commercialization of Telacebec for…
Aurobindo Pharma Clarification on Significant Volume Movement in Company’s Shares
Aurobindo Pharma has addressed recent trading volume increases in its securities, stating they are purely market-driven. The company confirms…
Cipla Arun Kakatkar Appointed as Global Chief People Officer
Cipla has announced the appointment of Arun Kakatkar as its new Global Chief People Officer and Senior Management Personnel, effective March…
Godrej Properties Sells Homes Worth Over INR 2,000 Crore at Godrej Trilogy Launch
Godrej Properties announced sales of homes worth over INR 2,000 crore in Phase 1 of the Godrej Trilogy project in Worli, Mumbai. The project…